The new approval completes a surprise turnaround for Blenrep, which was initially cleared in 2020 but pulled from the market ...

The U.S. Food and Drug Administration has approved British drugmaker GSK's blood cancer drug, Blenrep, in one combination ...

US regulators approved GSK Plc’s blood cancer drug, a decision that will allow the company to bring the medicine back to the ...

GSK’s chief executive said the company has shown its commitment to pioneering treatments after winning US approval for a ...

A pharmaceutical factory which ceased production earlier this year has been bought by Britain's biggest defence firm. BAE ...

The UK's drugs cost-effectiveness watchdog has given a positive recommendation for ViiV Healthcare's HIV drug, enabling ...

The FTSE 100 Index rose for four consecutive days and reached its all-time high of £9,578 as traders reacted to key earnings ...

The Food and Drug Administration on Thursday delivered a split decision to a blood cancer drug from GSK, approving its use in ...

The immediate consequences of the disappointing result are a big reduction in workforce at South San Francisco-based Alector, ...

Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion to support the approval of Shingrix ...

Alector Therapeutics is shelving a GSK-partnered antibody after the asset failed to slow disease progression in patients with ...